<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1218</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>14972550</PubmedId>
            <Abstract>CD8 T cells play an important role in controlling Ebola infection and in mediating vaccine-induced protective immunity, yet little is known about antigenic targets in Ebola that are recognized by CD8 T cells. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding Ebola nucleoprotein (NP). CD8 T-cell responses were mapped to a H-2(d)-restricted epitope (NP279-288) and two H-2(b)-restricted epitopes (NP44-52 and NP288-296). The identification of these epitopes will facilitate studies of immune correlates of protection and the evaluation of vaccine strategies in murine models of Ebola infection.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>224-30</ArticlePages>
            <ArticleTitle>Identification of murine T-cell epitopes in Ebola virus nucleoprotein.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Simmons</LastName>
                    <ForeName>Graham</ForeName>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Anee</ForeName>
                </Author>
                <Author>
                    <LastName>Rennekamp</LastName>
                    <ForeName>Andrew J</ForeName>
                </Author>
                <Author>
                    <LastName>Fan</LastName>
                    <ForeName>Xin</ForeName>
                </Author>
                <Author>
                    <LastName>Bates</LastName>
                    <ForeName>Paul</ForeName>
                </Author>
                <Author>
                    <LastName>Shen</LastName>
                    <ForeName>Hao</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6076, USA.</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;Histocompatibility Antigens Class I;Nucleocapsid Proteins;Viral Vaccines;nucleocapsid protein, Ebola virus</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; CD8-Positive T-Lymphocytes(immunology); Disease Models, Animal; Ebolavirus(immunology); Epitope Mapping; Epitopes, T-Lymphocyte(immunology); Hemorrhagic Fever, Ebola(immunology; prevention &amp; control); Histocompatibility Antigens Class I(metabolism); Humans; Immunization; Immunization, Secondary; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Nucleocapsid Proteins(chemistry; immunology); Viral Vaccines(administration &amp; dosage; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>318</Volume>
                <Issue>1</Issue>
                <Title>Virology</Title>
                <Issn>1096-0341</Issn>
                <MedlineTa>Virology</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>NP279-288</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SFKAALSSLA</LinearSequence>
                        <StartingPosition>279</StartingPosition>
                        <EndingPosition>288</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18272.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>128952</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 225</LocationOfData>
                <EpitopeId>57802</EpitopeId>
                <ReferenceStartingPosition>279</ReferenceStartingPosition>
                <ReferenceEndingPosition>288</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1C</LocationOfData>
                        <TCellId>17804</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks-old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P18272.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>128952</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with DNA plasmid via bilateral injections into the anterior tibial muscles, intraperitoneally with Adenovirus, and intravenously with recombinant Listeria monocytogenes expressing Nucleoprotein.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with DNA expressing Ebola Zaire Mayinga Nucleoprotein,followed by boosting with replication-deficient adenovirus encoding Nucleoprotein, and finally with recombinant Listeria monocytogenes expressing Nucleoprotein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP279-288</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SFKAALSSLA</LinearSequence>
                                        <StartingPosition>279</StartingPosition>
                                        <EndingPosition>288</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P18272.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>128952</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>4.83</QuantitativeMeasurement>
                            <AssayComments>Splenocytes were harvested 7 days after the final immunization and re-stimulated in vitro with arrayed pools of overlapping peptides corresponding to nucleoprotein. Positive reactivity was found in two pools sharing the NP276-291 peptide, which was further mapped  to NP279-288 and subsequently assayed.  A DNA-nucleoprotein prime followed by an adenovirus-nucleoprotein boost was sufficient to stimulate a strong CD8+ T-cell response to NP279â€“288.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP96-111</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VKYLEGHGFRFEVKKR</LinearSequence>
                        <StartingPosition>96</StartingPosition>
                        <EndingPosition>111</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18272.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>128952</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>69341</EpitopeId>
                <ReferenceStartingPosition>96</ReferenceStartingPosition>
                <ReferenceEndingPosition>111</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>17805</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks-old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P18272.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>128952</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with DNA plasmid via bilateral injections into the anterior tibial muscles, intraperitoneally with Adenovirus, and intravenously with recombinant Listeria monocytogenes expressing Nucleoprotein.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with DNA expressing Ebola Zaire Mayinga Nucleoprotein,followed by boosting with replication-deficient adenovirus encoding Nucleoprotein, and finally with recombinant Listeria monocytogenes expressing Nucleoprotein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP96-111</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VKYLEGHGFRFEVKKR</LinearSequence>
                                        <StartingPosition>96</StartingPosition>
                                        <EndingPosition>111</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P18272.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>128952</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.07</QuantitativeMeasurement>
                            <AssayComments>Splenocytes were harvested 7 days after the final immunization and re-stimulated in vitro with arrayed pools of overlapping peptides corresponding to nucleoprotein.  This peptide was found in one of the two pools and gave a negative response as was expected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP26-41</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TAGLSVQQGIVRQRVI</LinearSequence>
                        <StartingPosition>26</StartingPosition>
                        <EndingPosition>41</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18272.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>128952</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>62856</EpitopeId>
                <ReferenceStartingPosition>26</ReferenceStartingPosition>
                <ReferenceEndingPosition>41</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2B</LocationOfData>
                        <TCellId>17817</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>6-8 weeks-old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P18272.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>128952</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with DNA plasmid via bilateral injections into the anterior tibial muscles, intraperitoneally with Adenovirus, and intravenously with recombinant Listeria monocytogenes expressing Nucleoprotein.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with DNA expressing Ebola Zaire Mayinga Nucleoprotein,followed by boosting with replication-deficient adenovirus encoding Nucleoprotein, and finally with recombinant Listeria monocytogenes expressing Nucleoprotein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>167</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP26-41</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TAGLSVQQGIVRQRVI</LinearSequence>
                                        <StartingPosition>26</StartingPosition>
                                        <EndingPosition>41</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P18272.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>128952</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.27</QuantitativeMeasurement>
                            <AssayComments>Splenocytes were harvested 7 days after the final immunization and re-stimulated in vitro with arrayed pools of overlapping peptides corresponding to nucleoprotein.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP393-402</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AMVTLRKERL</LinearSequence>
                        <StartingPosition>393</StartingPosition>
                        <EndingPosition>402</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18272.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>128952</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 226</LocationOfData>
                <EpitopeId>3209</EpitopeId>
                <ReferenceStartingPosition>393</ReferenceStartingPosition>
                <ReferenceEndingPosition>402</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2C</LocationOfData>
                        <TCellId>17821</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>6-8 weeks-old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P18272.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>128952</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with DNA plasmid via bilateral injections into the anterior tibial muscles, intraperitoneally with Adenovirus, and intravenously with recombinant Listeria monocytogenes expressing Nucleoprotein.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with DNA expressing Ebola Zaire Mayinga Nucleoprotein,followed by boosting with replication-deficient adenovirus encoding Nucleoprotein, and finally with recombinant Listeria monocytogenes expressing Nucleoprotein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>167</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP393-402</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AMVTLRKERL</LinearSequence>
                                        <StartingPosition>393</StartingPosition>
                                        <EndingPosition>402</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P18272.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>128952</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.1</QuantitativeMeasurement>
                            <AssayComments>Splenocytes were harvested 7 days after the final immunization and re-stimulated in vitro with arrayed pools of overlapping peptides corresponding to nucleoprotein.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP401-416</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLAKLTEAITAASLPK</LinearSequence>
                        <StartingPosition>401</StartingPosition>
                        <EndingPosition>416</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18272.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>128952</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>54471</EpitopeId>
                <ReferenceStartingPosition>401</ReferenceStartingPosition>
                <ReferenceEndingPosition>416</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2B</LocationOfData>
                        <TCellId>17822</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>6-8 weeks-old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P18272.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>128952</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with DNA plasmid via bilateral injections into the anterior tibial muscles, intraperitoneally with Adenovirus, and intravenously with recombinant Listeria monocytogenes expressing Nucleoprotein.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with DNA expressing Ebola Zaire Mayinga Nucleoprotein,followed by boosting with replication-deficient adenovirus encoding Nucleoprotein, and finally with recombinant Listeria monocytogenes expressing Nucleoprotein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>167</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP401-416</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLAKLTEAITAASLPK</LinearSequence>
                                        <StartingPosition>401</StartingPosition>
                                        <EndingPosition>416</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P18272.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>128952</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.16</QuantitativeMeasurement>
                            <AssayComments>Splenocytes were harvested 7 days after the final immunization and re-stimulated in vitro with arrayed pools of overlapping peptides corresponding to nucleoprotein.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP44-52</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YQVNNLEEI</LinearSequence>
                        <StartingPosition>44</StartingPosition>
                        <EndingPosition>52</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18272.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>128952</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 226</LocationOfData>
                <EpitopeId>75566</EpitopeId>
                <ReferenceStartingPosition>44</ReferenceStartingPosition>
                <ReferenceEndingPosition>52</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2C</LocationOfData>
                        <TCellId>17823</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>6-8 weeks-old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P18272.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>128952</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with DNA plasmid via bilateral injections into the anterior tibial muscles, intraperitoneally with Adenovirus, and intravenously with recombinant Listeria monocytogenes expressing Nucleoprotein.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with DNA expressing Ebola Zaire Mayinga Nucleoprotein,followed by boosting with replication-deficient adenovirus encoding Nucleoprotein, and finally with recombinant Listeria monocytogenes expressing Nucleoprotein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>167</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP44-52</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YQVNNLEEI</LinearSequence>
                                        <StartingPosition>44</StartingPosition>
                                        <EndingPosition>52</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P18272.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>128952</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>8.52</QuantitativeMeasurement>
                            <AssayComments>Splenocytes were harvested 7 days after the final immunization and re-stimulated in vitro with arrayed pools of overlapping peptides corresponding to nucleoprotein. Positive reactivity was found in two pools sharing the NP41-56 peptide, which was further mapped to NP44-52 and subsequently assayed.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP388-396</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FQQTNAMVT</LinearSequence>
                        <StartingPosition>388</StartingPosition>
                        <EndingPosition>396</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18272.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>128952</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 226</LocationOfData>
                <EpitopeId>17527</EpitopeId>
                <ReferenceStartingPosition>388</ReferenceStartingPosition>
                <ReferenceEndingPosition>396</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2C</LocationOfData>
                        <TCellId>17824</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>6-8 weeks-old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P18272.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>128952</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with DNA plasmid via bilateral injections into the anterior tibial muscles, intraperitoneally with Adenovirus, and intravenously with recombinant Listeria monocytogenes expressing Nucleoprotein.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with DNA expressing Ebola Zaire Mayinga Nucleoprotein,followed by boosting with replication-deficient adenovirus encoding Nucleoprotein, and finally with recombinant Listeria monocytogenes expressing Nucleoprotein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>167</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP388-396</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FQQTNAMVT</LinearSequence>
                                        <StartingPosition>388</StartingPosition>
                                        <EndingPosition>396</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P18272.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>128952</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.15</QuantitativeMeasurement>
                            <AssayComments>Splenocytes were harvested 7 days after the final immunization and re-stimulated in vitro with arrayed pools of overlapping peptides corresponding to nucleoprotein. Positive reactivity was found in two pools sharing the NP386-401 peptide, which was further mapped to NP388-396 and subsequently assayed.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

